Innovative Radiopharmaceuticals in Oncology and Neurology

The aim of this Research Topic was to assemble a series of articles describing basic, preclinical and clinical research studies on radiopharmaceuticals and nuclear medicine. The articles were written by attendees of the third Nuclear Technologies for Health Symposium (NTHS, 10th-11th March 2015, Nan...

সম্পূর্ণ বিবরণ

সংরক্ষণ করুন:
গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক: Michel Cherel, Jacques Barbet, Francoise Kraeber-Bodere, Denis Guilloteau
বিন্যাস: Online
ভাষা:ইংরেজি
প্রকাশিত: Frontiers Media SA 2021
বিষয়গুলি:
অনলাইন ব্যবহার করুন:23479
ট্যাগগুলো: ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
_version_ 1869522459281063936
author Michel Cherel
Jacques Barbet
Francoise Kraeber-Bodere
Denis Guilloteau
author_browse Denis Guilloteau
Francoise Kraeber-Bodere
Jacques Barbet
Michel Cherel
author_facet Michel Cherel
Jacques Barbet
Francoise Kraeber-Bodere
Denis Guilloteau
author_sort Michel Cherel
collection Directory of Open Access Books
description The aim of this Research Topic was to assemble a series of articles describing basic, preclinical and clinical research studies on radiopharmaceuticals and nuclear medicine. The articles were written by attendees of the third Nuclear Technologies for Health Symposium (NTHS, 10th-11th March 2015, Nantes, Frances) under the auspices of the IRON LabEx (Innovative Radiopharmaceuticals for Oncology and Neurology Laboratory of Excellence). This French network, gathering approximately 160 scientists from 12 academic research teams (Funded by “investissements d’Avenir”), fosters transdisciplinary projects between teams with expertise in chemistry, radiochemistry, radiopharmacy, formulation, biology, nuclear medicine and medical physics. The 12 articles within this resulting eBook present a series of comprehensive reviews and original research papers on multimodality imaging and targeted radionuclide therapy; illustrating the different facets of studies currently conducted in these domains.
format Online
id doab-20.500.12854ir-50301
institution Directory of Open Access Books
language eng
publishDate 2021
publishDateRange 2021
publishDateSort 2021
publisher Frontiers Media SA
publisherStr Frontiers Media SA
record_format ojs
spelling doab-20.500.12854ir-503012024-03-30T23:23:01Z Innovative Radiopharmaceuticals in Oncology and Neurology Michel Cherel Jacques Barbet Francoise Kraeber-Bodere Denis Guilloteau R5-920 multimodality imaging PET imaging targeted radionuclide therapy Radiopharmaceuticals theranostic Pretargeted radioimmunotherapy personalized medicine thema EDItEUR::M Medicine and Nursing The aim of this Research Topic was to assemble a series of articles describing basic, preclinical and clinical research studies on radiopharmaceuticals and nuclear medicine. The articles were written by attendees of the third Nuclear Technologies for Health Symposium (NTHS, 10th-11th March 2015, Nantes, Frances) under the auspices of the IRON LabEx (Innovative Radiopharmaceuticals for Oncology and Neurology Laboratory of Excellence). This French network, gathering approximately 160 scientists from 12 academic research teams (Funded by “investissements d’Avenir”), fosters transdisciplinary projects between teams with expertise in chemistry, radiochemistry, radiopharmacy, formulation, biology, nuclear medicine and medical physics. The 12 articles within this resulting eBook present a series of comprehensive reviews and original research papers on multimodality imaging and targeted radionuclide therapy; illustrating the different facets of studies currently conducted in these domains. 2021-02-11T16:17:56Z 2021-02-11T16:17:56Z 2017-08-28 14:01:09 2017 book 23479 16648714 9782889451746 https://directory.doabooks.org/handle/20.500.12854/50301 eng Frontiers Research Topics image/jpeg Attribution 4.0 International http://www.frontiersin.org/books/Innovative_Radiopharmaceuticals_in_Oncology_and_Neurology/1193#nogo http://journal.frontiersin.org/researchtopic/3871/innovative-radiopharmaceuticals-in-oncology-and-neurology Frontiers Media SA 10.3389/978-2-88945-174-6 10.3389/978-2-88945-174-6 bf5ce210-e72e-4860-ba9b-c305640ff3ae 9782889451746 114 open access
spellingShingle R5-920
multimodality imaging
PET imaging
targeted radionuclide therapy
Radiopharmaceuticals
theranostic
Pretargeted radioimmunotherapy
personalized medicine
thema EDItEUR::M Medicine and Nursing
Michel Cherel
Jacques Barbet
Francoise Kraeber-Bodere
Denis Guilloteau
Innovative Radiopharmaceuticals in Oncology and Neurology
title Innovative Radiopharmaceuticals in Oncology and Neurology
title_full Innovative Radiopharmaceuticals in Oncology and Neurology
title_fullStr Innovative Radiopharmaceuticals in Oncology and Neurology
title_full_unstemmed Innovative Radiopharmaceuticals in Oncology and Neurology
title_short Innovative Radiopharmaceuticals in Oncology and Neurology
title_sort innovative radiopharmaceuticals in oncology and neurology
topic R5-920
multimodality imaging
PET imaging
targeted radionuclide therapy
Radiopharmaceuticals
theranostic
Pretargeted radioimmunotherapy
personalized medicine
thema EDItEUR::M Medicine and Nursing
topic_facet R5-920
multimodality imaging
PET imaging
targeted radionuclide therapy
Radiopharmaceuticals
theranostic
Pretargeted radioimmunotherapy
personalized medicine
thema EDItEUR::M Medicine and Nursing
url 23479
work_keys_str_mv AT michelcherel innovativeradiopharmaceuticalsinoncologyandneurology
AT jacquesbarbet innovativeradiopharmaceuticalsinoncologyandneurology
AT francoisekraeberbodere innovativeradiopharmaceuticalsinoncologyandneurology
AT denisguilloteau innovativeradiopharmaceuticalsinoncologyandneurology